2025年关于胃食道逆流性疾病的首尔共识的重点更新:关于抑制酸性治疗的基于证据的建议
Cheal Wung Huh1, Jin Won Chang2, Nak-Hoon Son3
1Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
这次2025年更新完善了胃食道逆流性疾病 (GERD) 管理,整合了关于抑制酸性疗法和诊断的新证据. 它为GERD表型和个性化治疗策略提供了最新的建议.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃食道逆流性疾病 (GERD) 是一种常见的胃肠道疾病,需要更新管理策略.
- 酸抑制疗法和诊断方法的最新进展需要对现有的共识指南进行集中更新.
- 2020年首尔共识提供了一个基础,但新的证据需要进一步细化,特别是关于亚洲人口.
研究的目的:
- 根据最新的科学证据,更新GERD的定义和医疗治疗建议.
- 纳入最近在抑制酸性疗法的进展,包括竞争性酸阻断剂 (P-CABs),以及更新的诊断框架,如里昂共识2.0.0.
- 为各种GERD表型提供基于证据的初始治疗,长期维持和个性化治疗指南,考虑亚洲的区域因素.
主要方法:
- 进行了系统审查和元分析,以综合新证据.
- 专家的共识被用来制定基于确定的临床问题 (人群,干预,比较,结果) 的建议.
- 该研究建立在2020年首尔共识的基础上,并将研究结果与里昂共识2.0框架相结合.
主要成果:
- 六个关键陈述提供了关于GERD定义,分类和治疗的最新指导.
- 建议涉及针对GERD表型 (非侵蚀性,轻微侵蚀性,严重侵蚀性食道炎) 的初始和长期管理.
- 详细介绍了用于剂量优化和抑制酸性疗法的长期安全性的策略.
结论:
- 这些更新的指导方针为管理GERD提供了精细的,基于证据的策略,特别包括P-CAB和更新的诊断.
- 这些建议支持针对不同GERD表型和患者群体的个性化治疗决定,包括亚洲地区的患者群体.
- 医疗保健提供者可以利用这些指南来优化GERD管理,以改善患者的治疗结果和长期安全.
更多相关视频
08:25Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
04:05Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
Published on: August 22, 2025
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
